Caret Pharma grows footprint with Fiber Choice acquisition

BOCA RATON, Fla. — Caret Pharma today announced it has entered into an agreement with Moberg Pharma to acquire the assets of Fiber Choice, a line of dietary supplements containing 100% natural, prebiotic fiber.

Fiber Choice will be marketed by IM HealthScience, a subsidiary of Caret Pharma’s parent company, Caret Group. It will join a growing digestive health product portfolio that already includes IBgard (for irritable bowel syndrome) and FDgard (for functional dyspepsia).

“We are pleased to welcome Fiber Choice to our family of companies. In a time of consumer empowerment and rising healthcare costs, people are taking a more active role in managing their own health-and-wellness. We believe Fiber Choice offers these consumers and their healthcare providers an important option,” said Fred Hassan, founder and chairman of Caret Group.